期刊
ANNUAL REVIEW OF MEDICINE
卷 61, 期 -, 页码 105-119出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev.med.60.041807.123500
关键词
alveolar proteinosis; interstitial lung disease; respiratory distress syndrome; pulmonary fibrosis; pulmonary alveolar microlithiasis
资金
- [NHLBI-HL085610]
- [HL061646]
- [HL090156]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090156, R01HL085610, P01HL061646] Funding Source: NIH RePORTER
The alveolar region of the lung creates an extensive epithelial surface that mediates the transfer of oxygen and carbon dioxide required for respiration after birth. Maintenance of pulmonary function depends on the function of type II epithelial cells that synthesize and secrete pulmonary surfactant lipids and proteins, reducing the collapsing forces created at the air-liquid interface in the alveoli. Genetic and acquired disorders associated with the surfactant system cause both acute and chronic lung disease. Mutations in the ABCA3, SFTPA, SFTPB, SPTPC, SCL34A2, and TERT genes disrupt type II cell function and/or surfactant homeostasis, causing neonatal respiratory failure and chronic interstitial lung disease. Defects in GM-CSF receptor function disrupt surfactant clearance, causing pulmonary alveolar proteinosis. Abnormalities in the surfactant system and disruption of type II cell homeostasis underlie the pathogenesis of pulmonary disorders previously considered idiopathic, providing the basis for improved diagnosis and therapies of these rare lung diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据